Treatments to prevent relapse in AML

TREATMENTS FOR MDS & SECONDARY AMLПодробнее

Targeting RAS proteins may prevent relapse in Acute Myeloid LeukemiaПодробнее

The current landscape for the treatment of R/R AML in the post-transplant settingПодробнее

Unmet needs in AML: TP53 mutations and maintenance therapyПодробнее

Post-HCT relapse monitoring and managementПодробнее

What time is the right time for transplantation?Подробнее

Advances in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (AML)Подробнее

Approaching patients with MDS and AML who relapse after alloSCT & strategies to prevent relapseПодробнее

Maintenance Therapy after Transplant: Acute Myeloid Leukemia (AML)Подробнее

Optimising transplant outcome in adults allografted for AMLПодробнее

Treatment approaches for patients with R/R AML and the importance of preventing relapseПодробнее

Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after RelapseПодробнее

Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after RelapseПодробнее

What is maintenance therapy? #AMLПодробнее

Refractory/Relapsed AML - Why and How to Treat?Подробнее

Outcomes & treatment options for patients with AML who relapse after alloHSCTПодробнее

The role of NK cells in preventing relapse in leukemiaПодробнее

What new treatments are there for relapsed acute myeloid leukemia?Подробнее

Treatment Failure and Relapse in Acute Myeloid Leukemia (AML)Подробнее

Maintenance and Continuous Treatment in Acute Myeloid LeukemiaПодробнее